Clinical Trials Browser

Active not recruiting × Pluvicto × 30 days × Clear all

NCT05114746 2026-03-16

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04720157 2026-03-11

PSMAddition

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT05849298 2026-03-03

PSMACare

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06964958 2026-02-24

LASER

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04689828 2026-02-20

PSMAfore

Phase 3 Active not recruiting

469 enrolled 11 charts 1 FDA

Prostatic Neoplasms